# CRYSVITA

NDC: 42747-203
Generic name: Burosumab
Labeler / Manufacturer: Kyowa Kirin, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20180418

FDA application: BLA761068

## Active ingredients

- BUROSUMAB: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42747-203"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42747-203
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=102f96a0-6e3a-4fc1-b204-34d604683af6